Third Quarter
Highlights:
- Sales were $662 million, an increase of 2% year-over-year
and in-line with mid-point of guidance
- Earnings per diluted share were $2.04
- Adjusted earnings per diluted share were $2.41, $0.08 above
the mid-point of guidance
Updated Full-Year
Guidance:
- Increasing full fiscal year 2024 revenue guidance to reflect
the addition of Atrion acquisition
- Maintaining full fiscal year 2024 adjusted earnings per
diluted share guidance, inclusive of the slightly dilutive fourth
quarter Atrion acquisition impact
Nordson Corporation (Nasdaq: NDSN) today reported results for
the fiscal third quarter ended July 31, 2024. Sales were $662
million, compared to the prior year’s third quarter sales of $649
million. The third quarter 2024 sales included a favorable
acquisition impact of 4%, partially offset by an organic sales
decrease of 1% and unfavorable currency translation of 1%. The
organic sales decrease was driven by lower demand in electronics
and medical product lines, partially offset by growth in packaging,
nonwovens, and optical sensors product lines.
Net income was $117 million, or $2.04 of earnings per diluted
share, compared to prior year’s third quarter net income of $128
million, or $2.22 of earnings per diluted share. Adjusted net
income was $138 million, a decrease from the prior year adjusted
net income of $147 million. Third quarter 2024 adjusted earnings
per diluted share were $2.41, a 6% decrease from the prior year
adjusted earnings per diluted share of $2.55. The decrease reflects
increased interest expense from prior year acquisitions and
slightly lower overall operating margins.
EBITDA in the third quarter was $208 million, or 31% of sales,
compared to prior year EBITDA of $208 million, or 32% of sales.
EBITDA was flat as improved gross margins were offset by higher
selling and administrative expenses, including the first-year
effect of the ARAG acquisition.
Commenting on the Company’s fiscal 2024 third quarter results,
Nordson President and Chief Executive Officer Sundaram Nagarajan
said, “We delivered third quarter revenue in line with our
expectations, driven by strong organic growth in our industrial
product lines. Our Advanced Technology Solutions segment
sequentially grew compared to second quarter, as order entry
steadily improves in electronics end markets. Across the company,
the teams executed another solid operating performance delivering
strong gross margins and 31% EBITDA margin. Overall, I am pleased
with our focus on the customer while managing profitability well
against headwinds in select businesses.”
Third Quarter Segment
Results
Industrial Precision Solutions sales of $371 million increased
10% from the prior year, inclusive of a favorable acquisition
impact of 7%, an organic sales increase of 4% and unfavorable
currency translation of 1%. The organic sales increase was driven
primarily by packaging and nonwovens product lines. Operating
profit was $118 million, an increase of $3 million from the prior
year. EBITDA in the quarter was $135 million, or 36% of sales, a
10% increase from the prior year third quarter EBITDA of $122
million, or 36% of sales. The year-over-year increase was driven by
the ARAG acquisition, and higher organic sales and gross
profit.
Medical and Fluid Solutions sales of $167 million decreased 2%
compared to the prior year third quarter. The decrease was driven
by lower demand in interventional solutions and fluid components
product lines. Operating profit was $48 million, a decrease of $6
million from the prior year. EBITDA in the quarter was $62 million,
or 37% of sales, down versus the prior year third quarter EBITDA of
$68 million, or 40% of sales.
Advanced Technology Solutions sales of $124 million decreased
11% compared to the prior year third quarter, driven by lower
organic sales and unfavorable currency translation of 1%. While
sequentially higher, the organic sales decrease compared to prior
year was driven by softness in electronics processing and x-ray and
test product lines, offset by growth in optical sensors product
lines. Operating profit was $23 million, a decrease of $4 million
from the prior year. EBITDA in the quarter was $26 million, or 21%
of sales, a decrease from the prior year third quarter EBITDA of
$33 million, or 24% of sales.
Outlook
The Company is entering the fourth quarter of fiscal 2024 with
approximately $650 million in backlog, which continues to normalize
and remain concentrated in systems businesses. Based on current
visibility and order entry trends, the Company is increasing its
full-year revenue guidance range to $2,665 million - $2,705
million, inclusive of revenue from the Atrion acquisition in the
fiscal fourth quarter. The Company is tightening full-year adjusted
earnings per diluted share to the range of $9.45 - $9.65, unchanged
at the midpoint, though now inclusive of the slightly dilutive
Atrion impact in the fiscal fourth quarter.
Reflecting on the outlook, Nagarajan continued, “Throughout
2024, we have remained focused on delivering high quality operating
performance in a dynamic environment. The diversification of our
product portfolio, geographic exposure, mix of recurring revenue,
in addition to the NBS Next growth framework and the contributions
of our recent acquisitions, are positioning us well to end the year
in line with record fiscal 2023 revenue. I remain pleased with our
ability to manage profitability during this period, while remaining
invested in the long-term objectives of the business.”
Nordson management will provide additional commentary on these
results and outlook during its previously announced webcast on
Thursday, August 22, 2024 at 8:30 a.m. eastern time, which can be
accessed at https://investors.nordson.com. Information about
Nordson’s investor relations and shareholder services is available
from Lara Mahoney, vice president, investor relations and corporate
communications at (440) 204-9985 or lara.mahoney@nordson.com.
The Company’s definition of adjusted earnings excludes
acquisition related amortization for both current and historical
periods. It is not possible for the Company to identify the amount
or significance of future adjustments associated with acquisition
and integration costs, restructuring costs, acquisition-related
amortization, certain non-operating or income tax items, or other
non-routine costs that the Company adjusts in the presentation of
adjusted earnings guidance. These items are dependent on future
events that are not reasonably estimable at this time. Accordingly,
the Company is unable to reconcile without unreasonable effort the
forecasted range of adjusted earnings guidance to a comparable GAAP
range.
Certain statements contained in this release are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements may be identified by
terminology such as “may,” “will,” “should,” “could,” “expects,”
“anticipates,” “believes,” “projects,” “forecasts,” “outlook,”
“guidance,” “continue,” “target,” or the negative of these terms or
comparable terminology. These statements reflect management’s
current expectations and involve a number of risks and
uncertainties. These risks and uncertainties include, but are not
limited to, U.S. and international economic conditions; financial
and market conditions; currency exchange rates and devaluations;
possible acquisitions, including the Company’s ability to
successfully integrate acquisitions; the Company’s ability to
successfully divest or dispose of businesses that are deemed not to
fit with its strategic plan; the effects of changes in U.S. trade
policy and trade agreements; the effects of changes in tax law; and
the possible effects of events beyond our control, such as
political unrest, including the conflict between Russia and
Ukraine, acts of terror, natural disasters and pandemics, including
the recent coronavirus (COVID-19) pandemic and the other factors
discussed in Item 1A (Risk Factors) in the Company’s most recently
filed Annual Report on Form 10-K and in its Forms 10-Q filed with
the Securities and Exchange Commission, which should be reviewed
carefully. The Company undertakes no obligation to update or revise
any forward-looking statement in this press release.
Nordson Corporation is an innovative precision technology
company that leverages a scalable growth framework through an
entrepreneurial, division-led organization to deliver top tier
growth with leading margins and returns. The Company’s direct sales
model and applications expertise serves global customers through a
wide variety of critical applications. Its diverse end market
exposure includes consumer non-durable, medical, electronics and
industrial end markets. Founded in 1954 and headquartered in
Westlake, Ohio, the Company has operations and support offices in
over 35 countries. Visit Nordson on the web at www.nordson.com,
linkedin/Nordson, or www.facebook.com/nordson.
NORDSON
CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(Dollars in thousands except for
per-share amounts)
Three Months Ended
Nine Months Ended
July 31, 2024
July 31, 2023
July 31, 2024
July 31, 2023
Sales
$
661,604
$
648,677
$
1,945,439
$
1,909,319
Cost of sales
292,603
288,357
862,134
868,007
Gross profit
369,001
360,320
1,083,305
1,041,312
Gross margin %
55.8
%
55.5
%
55.7
%
54.5
%
Selling & administrative expenses
201,943
189,324
588,196
553,590
Operating profit
167,058
170,996
495,109
487,722
Interest expense - net
(17,776
)
(11,486
)
(56,729
)
(30,904
)
Other income (expense) - net
152
2,542
(971
)
(2,059
)
Income before income taxes
149,434
162,052
437,409
454,759
Income taxes
32,107
34,161
92,293
95,044
Net income
$
117,327
$
127,891
$
345,116
$
359,715
Weighted-average common shares
outstanding:
Basic
57,229
56,989
57,171
57,114
Diluted
57,624
57,530
57,620
57,657
Earnings per share:
Basic earnings
$
2.05
$
2.24
$
6.04
$
6.30
Diluted earnings
$
2.04
$
2.22
$
5.99
$
6.24
NORDSON
CORPORATION
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands)
July 31, 2024
October 31, 2023
Cash and cash equivalents
$
165,324
$
115,679
Receivables - net
538,541
590,886
Inventories - net
438,167
454,775
Other current assets
82,106
67,970
Total current assets
1,224,138
1,229,310
Property, plant and equipment - net
401,415
392,846
Goodwill
2,785,773
2,784,201
Other assets
793,044
845,413
$
5,204,370
$
5,251,770
Notes payable and debt due within one
year
$
96,288
$
115,662
Accounts payable and accrued
liabilities
421,979
466,427
Total current liabilities
518,267
582,089
Long-term debt
1,398,155
1,621,394
Other liabilities
434,191
450,227
Total shareholders' equity
2,853,757
2,598,060
$
5,204,370
$
5,251,770
NORDSON
CORPORATION
CONSOLIDATED STATEMENT OF CASH
FLOWS (Unaudited)
(Dollars in thousands)
Nine Months Ended
July 31, 2024
July 31, 2023
Cash flows from
operating activities:
Net income
$
345,116
$
359,715
Depreciation and amortization
99,646
80,637
Other non-cash items
15,435
18,523
Changes in operating assets and
liabilities and other
(385
)
19,197
Net cash provided by operating
activities
459,812
478,072
Cash flows from
investing activities:
Additions to property, plant and
equipment
(43,786
)
(24,244
)
Acquisition of businesses, net of cash
acquired
—
(377,843
)
Other - net
8,896
91
Net cash used in investing activities
(34,890
)
(401,996
)
Cash flows from
financing activities:
Issuance (repayment) of long-term debt
(244,355
)
73,956
Repayment of finance lease obligations
(4,505
)
(4,769
)
Dividends paid
(116,789
)
(111,547
)
Issuance of common shares
29,142
18,449
Purchase of treasury shares
(34,105
)
(78,163
)
Net cash provided used in financing
activities
(370,612
)
(102,074
)
Effect of exchange
rate change on cash:
(4,665
)
5,679
Net change in cash and cash
equivalents
49,645
(20,319
)
Cash and cash
equivalents:
Beginning of period
115,679
163,457
End of period
$
165,324
$
143,138
NORDSON
CORPORATION
SALES BY GEOGRAPHIC SEGMENT
(Unaudited)
(Dollars in thousands)
Three Months Ended
Sales Variance
July 31, 2024
July 31, 2023
Organic
Acquisitions
Currency
Total
SALES BY
SEGMENT
Industrial Precision Solutions
$
370,561
$
338,257
3.6
%
7.4
%
(1.4
)%
9.6
%
Medical and Fluid Solutions
166,737
170,871
(2.0
)%
—
%
(0.4
)%
(2.4
)%
Advanced Technology Solutions
124,306
139,549
(10.2
)%
—
%
(0.7
)%
(10.9
)%
Total sales
$
661,604
$
648,677
(0.9
)%
3.8
%
(0.9
)%
2.0
%
SALES BY
GEOGRAPHIC REGION
Americas
$
287,016
$
290,515
(3.4
)%
2.4
%
(0.2
)%
(1.2
)%
Europe
179,370
167,536
(2.0
)%
9.8
%
(0.7
)%
7.1
%
Asia Pacific
195,218
190,626
4.1
%
0.8
%
(2.5
)%
2.4
%
Total sales
$
661,604
$
648,677
(0.9
)%
3.8
%
(0.9
)%
2.0
%
Nine Months Ended
Sales Variance
July 31, 2024
July 31, 2023
Organic
Acquisitions
Currency
Total
SALES BY
SEGMENT
Industrial Precision Solutions
$
1,092,099
$
985,610
2.5
%
8.8
%
(0.5
)%
10.8
%
Medical and Fluid Solutions
495,229
491,683
0.9
%
—
%
(0.2
)%
0.7
%
Advanced Technology Solutions
358,111
432,026
(16.6
)%
—
%
(0.5
)%
(17.1
)%
Total sales
$
1,945,439
$
1,909,319
(2.2
)%
4.5
%
(0.4
)%
1.9
%
SALES BY
GEOGRAPHIC REGION
Americas
$
855,456
$
834,125
(0.3
)%
2.7
%
0.2
%
2.6
%
Europe
540,750
498,379
(4.5
)%
12.2
%
0.8
%
8.5
%
Asia Pacific
549,233
576,815
(3.1
)%
0.7
%
(2.4
)%
(4.8
)%
Total sales
$
1,945,439
$
1,909,319
(2.2
)%
4.5
%
(0.4
)%
1.9
%
NORDSON
CORPORATION
RECONCILIATION OF NON-GAAP
MEASURES - NET INCOME TO EBITDA (Unaudited)
(Dollars in thousands)
Three Months Ended
Nine Months Ended
July 31, 2024
July 31, 2023
July 31, 2024
July 31, 2023
Net income
$
117,327
$
127,891
$
345,116
$
359,715
Income taxes
32,107
34,161
92,293
95,044
Interest expense - net
17,776
11,486
56,729
30,904
Other expense - net
(152
)
(2,542
)
971
2,059
Depreciation and amortization
33,382
27,102
99,646
80,637
Inventory step-up amortization (1)
—
—
2,944
4,306
Severance and other
2,536
2,049
4,615
5,487
Acquisition-related costs (1)
5,160
7,732
5,757
13,721
EBITDA (non-GAAP) (2)
$
208,136
$
207,879
$
608,071
$
591,873
(1)
Represents fees, severance and non-cash
inventory charges associated with acquisitions.
(2)
EBITDA is a non-GAAP measure used by
management to evaluate the Company's ongoing operations. EBITDA is
defined as operating profit plus certain adjustments, such as
severance, fees and non-cash inventory charges associated with
acquisitions, plus depreciation and amortization.
NORDSON
CORPORATION
RECONCILIATION OF NON-GAAP
MEASURES - EBITDA (Unaudited)
(Dollars in thousands)
Three Months Ended
Nine Months Ended
July 31, 2024
July 31, 2023
July 31, 2024
July 31, 2023
SALES BY
SEGMENT
Industrial Precision Solutions
$
370,561
$
338,257
$
1,092,099
$
985,610
Medical and Fluid Solutions
166,737
170,871
495,229
491,683
Advanced Technology Solutions
124,306
139,549
358,111
432,026
Total sales
$
661,604
$
648,677
$
1,945,439
$
1,909,319
OPERATING
PROFIT
Industrial Precision Solutions
$
118,110
$
115,346
$
344,305
$
329,439
Medical and Fluid Solutions
48,374
54,019
143,467
141,326
Advanced Technology Solutions
22,945
27,083
60,767
70,136
Corporate
(22,371
)
(25,452
)
(53,430
)
(53,179
)
Total operating profit
$
167,058
$
170,996
$
495,109
$
487,722
OPERATING PROFIT
ADJUSTMENTS (1)
Industrial Precision Solutions
$
2,536
$
—
$
6,077
$
—
Medical and Fluid Solutions
—
—
—
1,479
Advanced Technology Solutions
—
2,049
2,078
14,303
Corporate
5,160
7,732
5,161
7,732
Total adjustments
$
7,696
$
9,781
$
13,316
$
23,514
DEPRECIATION
& AMORTIZATION
Industrial Precision Solutions
$
14,521
$
7,036
$
42,821
$
21,166
Medical and Fluid Solutions
13,553
14,133
40,822
41,441
Advanced Technology Solutions
3,368
3,834
10,093
11,656
Corporate
1,940
2,099
5,910
6,374
Total depreciation & amortization
$
33,382
$
27,102
$
99,646
$
80,637
EBITDA
(NON-GAAP) (2)
Industrial Precision Solutions
$
135,167
36%
$
122,382
36%
$
393,203
36%
$
350,605
36%
Medical and Fluid Solutions
61,927
37%
68,152
40%
184,289
37%
184,246
37%
Advanced Technology Solutions
26,313
21%
32,966
24%
72,938
20%
96,095
22%
Corporate
(15,271
)
(15,621
)
(42,359
)
(39,073
)
Total EBITDA
$
208,136
31%
$
207,879
32%
$
608,071
31%
$
591,873
31%
(1)
Represents severance as well as fees and
non-cash inventory charges associated with acquisitions.
(2)
EBITDA is a non-GAAP measure used by
management to evaluate the Company's ongoing operations. EBITDA is
defined as operating profit plus certain adjustments, such as
severance, fees and non-cash inventory charges associated with
acquisitions, plus depreciation and amortization.
NORDSON
CORPORATION
RECONCILIATION OF NON-GAAP
MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE
(Unaudited)
(Dollars in thousands)
Three Months Ended
Nine Months Ended
July 31, 2024
July 31, 2023
July 31, 2024
July 31, 2023
GAAP AS
REPORTED
Operating profit
$
167,058
$
170,996
$
495,109
$
487,722
Other / interest expense - net
(17,624
)
(8,944
)
(57,700
)
(32,963
)
Net income
117,327
127,891
345,116
359,715
Diluted earnings per share
$
2.04
$
2.22
$
5.99
$
6.24
Shares outstanding - diluted
57,624
57,530
57,620
57,657
OPERATING PROFIT
ADJUSTMENTS
Inventory step-up amortization
$
—
$
—
$
2,944
$
4,306
Acquisition-related costs
5,160
7,732
5,757
13,721
Severance and other
2,536
2,049
4,615
5,487
ACQUISITION
AMORTIZATION OF INTANGIBLES
$
19,202
$
13,922
57,412
41,839
Total adjustments
$
26,898
$
23,703
$
70,728
$
65,353
Adjustments net of tax
$
21,134
$
18,706
$
55,804
$
51,694
EPS effect of adjustments and other
discrete tax items
$
0.37
$
0.33
$
0.97
$
0.90
NON-GAAP
MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER
SHARE
Adjusted Net income (1)
$
138,461
$
146,597
$
400,920
$
411,409
Adjusted Diluted earnings per share
(2)
$
2.41
$
2.55
$
6.96
$
7.14
(1)
Adjusted net income is a non-GAAP measure defined as net income
plus tax effected adjustments and other discrete tax items.
(2)
Adjusted earnings per share is a non-GAAP
measure defined as GAAP EPS adjusted for tax effected adjustments
and other discrete tax items.
Management uses certain non-GAAP measures,
such as adjusted net income, adjusted EPS and EBITDA, internally to
make strategic decisions, forecast future results, and evaluate the
Company's current performance. Given management's use of these
non-GAAP measures, the Company believes these measures are
important to investors in understanding the Company's current and
future operating results as seen through the eyes of management. In
addition, management believes these non-GAAP measures are useful to
investors in enabling them to better assess changes in the
Company's core business across different time periods. Because
non-GAAP financial measures are not standardized, it may not be
possible to compare these financial measures to other companies'
non-GAAP financial measures, even if they have similar names.
Amounts may not add due to rounding.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240821934508/en/
Lara Mahoney Vice President, Investor Relations & Corporate
Communications 440.204.9985 Lara.Mahoney@nordson.com
Nordson (NASDAQ:NDSN)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Nordson (NASDAQ:NDSN)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024